Catalyst

Slingshot members are tracking this event:

The Medicines Company Announces Initiation of Phase II Study for its Investigational Anesthetic, ABP-700

Source Link:
http://www.themedicinescompany.com/investors/news/medicines-company-announces-initiation-phase-ii-study-its-investigational-anesthetic

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MDCO Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details
  • Phase II study to include 75 patients undergoing elective colonoscopies
  • Results anticipated later in 2016
  • Rapid phase transition following reports of Phase I clinical pharmacology, dosing and safety data at International Anesthesia Research Society and Euroanaesthesia 2016
  • Initiation of the VERONA Phase II-III development program
    • http://www.themedici...
    Slingshot Insights Explained
    JOIN FOR FREE TODAY
    Catalyst Date
    Occurred on:
    Jun 14, 2016
    Related Projects Image

    • Don’t see a project related to the catalyst you care about?

    Related Keywords Abp-700, Verona Program
    About Us
    Media Center
    Connect with Us
    © 2025 Slingshot Insights. All rights reserved.